Joel Greenblatt's VKTX Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 230,737 shares of Viking Therapeutics, Inc. (VKTX) worth $9 M, representing 0.02% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 6 quarters.
Based on 13F filings, Joel Greenblatt has maintained this position in VKTX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 169,683 shares. Largest reduction occurred in Q2 2026, reducing 30,041 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Viking Therapeutics (VKTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Viking Therapeutics (VKTX) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -30,041 | Reduce 11.52% | 230,737 | $39.01 |
| Q1 2026 | +21,549 | Add 9.01% | 260,778 | $32.54 |
| Q4 2025 | +69,546 | Add 40.99% | 239,229 | $35.18 |
| Q3 2025 | +169,683 | New Buy | 169,683 | $26.28 |
| Q2 2025 | -24,500 | Sold Out | 0 | $0.00 |
| Q1 2025 | +24,500 | New Buy | 24,500 | $24.15 |
Joel Greenblatt's Viking Therapeutics Investment FAQs
Joel Greenblatt first purchased Viking Therapeutics, Inc. (VKTX) in Q1 2025, acquiring 24,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Viking Therapeutics, Inc. (VKTX) for 6 quarters since Q1 2025.
Joel Greenblatt's largest addition to Viking Therapeutics, Inc. (VKTX) was in Q3 2025, adding 169,683 shares worth $4.46 M.
According to the latest 13F filing for Q2 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 230,737 shares of Viking Therapeutics, Inc. (VKTX), valued at approximately $9 M.
As of the Q2 2026 filing, Viking Therapeutics, Inc. (VKTX) represents approximately 0.02% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Viking Therapeutics, Inc. (VKTX) was 260,778 shares, as reported at the end of Q1 2026.